Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators

Journal of Clinical Oncology

Volumn 29, Issue 22, 2011, Pages 2959-2964

  Nam, Robert K ^a   Kattan, Michael W ^h   Chin, Joseph L ^f   Trachtenberg, John ^b   Singal, Rajiv ^c   Rendon, Ricardo ^g   Klotz, Laurence H ^a   Sugar, Linda ^a   Sherman, Christopher ^a   Izawa, Jonathan ^f   Bell, David ^g   Stanimirovic, Aleksandra ^a   Venkateswaran, Vasundara ^a   Diamandis, Eleftherios P ^e   Yu, Changhong ^h   Loblaw, D Andrew ^a   Narod, Steven A ^d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c TORONTO EAST GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER RISK; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RISK ASSESSMENT; BIOPSY; BLOOD; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; EVALUATION; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NOMOGRAM; PREDICTIVE VALUE; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VALIDATION STUDY;

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; AREA UNDER CURVE; BIOPSY; DECISION SUPPORT TECHNIQUES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 80051646902     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.6371     Document Type: Article

References (16)

1. Schröder FH, Hugosson J, Roobol MJ, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320-1328, 2009
2. Andriole GL, Crawford ED, Grubb RL 3rd, et al: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-1319, 2009
3. Nam RK, Toi A, Klotz LH, et al: Assessing individual risk for prostate cancer. J Clin Oncol 25:3582-3588, 2007. (Pubitemid 47372595)
4. Thompson IM, Ankerst DP, Chi C, et al: Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98:529-534, 2006 (Pubitemid 43898816)
5. Steyerberg EW, Vickers AJ, Cook NR, et al: Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 21:128-138, 2010
6. Gleason DF, Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64, 1974
7. Barry MJ, Fowler FJ Jr, O'Leary MP, et al: The American Urological Association symptom index for benign prostatic hyperplasia: The Measurement Committee of the American Urological Association. J Urol 148:1549-1557, 1992; discussion 1564
8. Vickers AJ, Elkin EB: Decision curve analysis: A novel method for evaluating prediction models. Med Decis Making 26:565-574, 2006 (Pubitemid 44728772)
9. Ross RW, Kantoff PW: Predicting outcomes in prostate cancer: How many more nomograms do we need? J Clin Oncol 25:3563-3564, 2007 (Pubitemid 47372589)
10. Nguyen CT, Yu C, Moussa A, et al: Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. J Urol 183:529-533, 2010
11. Eyre SJ, Ankerst DP, Wei JT, et al: Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. J Urol 182:2653-2658, 2009
12. Parekh DJ, Ankerst DP, Higgins BA, et al: External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population. Urology 68:1152-1155, 2006 (Pubitemid 44880388)
13. Hernandez DJ, Han M, Humphreys EB, et al: Predicting the outcome of prostate biopsy: Comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone. BJU Int 103:609-614, 2009
14. Kattan MW: Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets. Eur Urol 59:566-567, 2011
15. Steyerberg EW, Vickers AJ: Decision curve analysis: A discussion. Med Decis Making 28:146-149, 2008
16. Thompson IM, Pauler DK, Goodman PJ, et al: Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 350:2239-2246, 2004